• Construction of the Industrial Plan for the launch of a new business model in the orthopedic prosthesis sector.
• Management of all funding phases (equity raising, debt financing, H2020).
• Coordination of activities for grounding the entire business model (commercial launch, startup of the greenfield production site).
• Market launch of the innovative business model (customized prostheses thanks to innovative 3D printing technology, IoT management of patient information).
• Financial consolidation of the company until the exit.
• Equity funding for € 4.5 million.
• Obtaining an H2020 grant for an additional € 3 million.
• Obtaining CE and FDA marks.
• Consolidated company value at € 30 million (multiplication for the founding members at around 15x).
